Related Experiment Video
Updated: Apr 25, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Substituted dithiazole piperazine benzamides as novel amyloid beta peptide reducing agents
Hongjie Wang1, Ruizhi Wang1, Madepalli K Lakshmana1
1Torrey Pines Institute for Molecular Studies, Port Saint Lucie, FL 34987, United States.
Abstract:
Alzheimer's disease is a persistent neurodegenerative disorder of elderly characterized clinically by irreversible loss of memory due to accumulation of amyloid beta peptides within the amyloid plaques. We report the parallel synthesis and screening results of diverse substituted di-thiazole piperazine benzamides. A new compound TPI-1917-49 was identified as a promising amyloid reducing agent by lowering the levels of Aβ at least in two cell types and in vivo.
Related Concept Videos
Preparation of Amines: Reductive Amination of Aldehydes and Ketones
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

